Desbuquois syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1425OMIM:618870Q78.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Desbuquois syndrome (also known as Desbuquois dysplasia) is a rare autosomal recessive skeletal dysplasia characterized by severe prenatal and postnatal growth retardation, joint laxity, and distinctive skeletal abnormalities. The condition was first described by Georges Desbuquois in 1966. It primarily affects the skeletal system, with key features including short stature (often severe), round face, prominent bulging eyes, midface hypoplasia, and characteristic hand anomalies such as an extra ossification center adjacent to the second metacarpal (the so-called 'monkey wrench' or 'Swedish key' appearance on X-ray). Joint hyperlaxity is a hallmark feature and can lead to dislocations. Progressive scoliosis and kyphosis may also develop. Two main subtypes have been recognized: Type 1 (with the characteristic hand changes) and Type 2 (without the hand changes). Desbuquois syndrome is caused by mutations in several genes involved in proteoglycan biosynthesis and cartilage development, including CANT1 (calcium-activated nucleotidase 1), XYLT1, XYLT2, and B3GALT6, among others. The CANT1 gene is the most commonly implicated. These genes play critical roles in glycosaminoglycan synthesis, which is essential for normal cartilage and bone development. The condition can be associated with respiratory difficulties in infancy due to a narrow thorax, intellectual disability in some cases, and progressive joint and skeletal complications. There is currently no cure or disease-specific treatment for Desbuquois syndrome. Management is supportive and multidisciplinary, focusing on orthopedic interventions for skeletal deformities (including scoliosis management and treatment of joint dislocations), respiratory support when needed, physical therapy to optimize mobility, and monitoring of growth and development. Genetic counseling is recommended for affected families. Prognosis varies depending on the severity of skeletal and respiratory involvement, but many individuals survive into adulthood with appropriate supportive care.

Also known as:

Clinical phenotype terms— hover any for plain English:

Bell-shaped thoraxHP:0001591Patellar dislocationHP:0002999Abnormal femoral neck/head morphologyHP:0003366Disproportionate short-limb short statureHP:0008873Aplasia/Hypoplasia of the abdominal wall musculatureHP:0010318Coxa valgaHP:0002673
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Desbuquois syndrome.

View clinical trials →

No actively recruiting trials found for Desbuquois syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Desbuquois syndrome community →

No specialists are currently listed for Desbuquois syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Desbuquois syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Desbuquois syndromeForum →

No community posts yet. Be the first to share your experience with Desbuquois syndrome.

Start the conversation →

Latest news about Desbuquois syndrome

No recent news articles for Desbuquois syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Desbuquois syndrome

What is Desbuquois syndrome?

Desbuquois syndrome (also known as Desbuquois dysplasia) is a rare autosomal recessive skeletal dysplasia characterized by severe prenatal and postnatal growth retardation, joint laxity, and distinctive skeletal abnormalities. The condition was first described by Georges Desbuquois in 1966. It primarily affects the skeletal system, with key features including short stature (often severe), round face, prominent bulging eyes, midface hypoplasia, and characteristic hand anomalies such as an extra ossification center adjacent to the second metacarpal (the so-called 'monkey wrench' or 'Swedish key'

How is Desbuquois syndrome inherited?

Desbuquois syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Desbuquois syndrome typically begin?

Typical onset of Desbuquois syndrome is neonatal. Age of onset can vary across affected individuals.